This trial for recurrent malignant glioma is now available in 3 major centers in Texas. It is a new way to target radiation to the tumor. Early trial results reported promising extension of survival for recurrent glioblastoma.
Brain Tumor News Blast
Enter your email address to subscribe!
Copyright © 1993 - 2021 Musella Foundation- All Rights Reserved.
Website by LcsProductionDesign.com